Location of Repository

Alternative splicing of G protein-coupled receptors: physiology and pathophysiology

By Danijela Markovic and R. A. John Challiss

Abstract

This is the author's final draft of the paper published as Cellular and Molecular Life Sciences, 2009, 66 (20), pp. 3337-3352. The original publication is available at www.springerlink.com. Doi: 10.1007/s00018-009-0093-4The G protein-coupled receptors (GPCRs) are a superfamily of transmembrane receptors that have a broad distribution and can collectively recognise a diverse array of ligands. Activation or inhibition of GPCR signalling can affect many (patho)physiological processes, and consequently they are a major target for existing and emerging drug therapies. A common observation has been that the pharmacological, signalling and regulatory properties of GPCRs can differ in a cell- and tissue-specific manner. Such “phenotypic” diversity might be attributable to post-translational modifications and/or association of GPCRs with accessory proteins, however, post-transcriptional mechanisms are also likely to contribute. Although approximately 50% of GPCR genes are intronless, those that possess introns can undergo alternative splicing, generating GPCR subtype isoforms that may differ in their pharmacological, signalling and regulatory properties. In this review we shall highlight recent research into GPCR splice variation and discuss the potential consequences this might have for GPCR function in health and disease

Publisher: Springer Verlag
Year: 2009
DOI identifier: 10.1007/s00018-009-0093-4
OAI identifier: oai:lra.le.ac.uk:2381/8054
Journal:

Suggested articles

Preview

Citations

  1. (2001). A CaMK-IV responsive RNA element mediates depolarizationinduced alternative splicing of ion channels. doi
  2. (2007). A role for SC35 and hnRNPA1 in the determination of amyloid precursor protein isoforms. doi
  3. (2008). Aberrant RNA splicing and its functional consequences in cancer cells. doi
  4. (2002). Activation of orphan receptors by the hormone relaxin.
  5. (2006). Adenosine A2A receptor inactivation increases survival in polymicrobial sepsis. doi
  6. (2008). Alternative splicing determines the post-endocytic sorting fate of G-protein-coupled receptors. doi
  7. (2003). Alternative splicing in the nervous system: an emerging source of diversity and regulation. doi
  8. (1998). Alternative splicing of the D2 dopamine receptor messenger ribonucleic acid is modulated by activated sex steroid receptors in the MMQ prolactin cell line. doi
  9. (2007). Alternative splicing: an important mechanism for myometrial gene regulation that can be manipulated to target specific genes associated with preterm labour doi
  10. (2000). Antagonists of growth hormone-releasing hormone arrest the growth of MDA-MB-468 estrogen-independent human breast cancers in nude mice. doi
  11. (2006). Antagonists of growth hormone-releasing hormone in oncology. doi
  12. (2006). Behavioral sensitization, alternative splicing, and D3 dopamine receptor-mediated inhibitory function. doi
  13. (2004). Characterization of a common susceptibility locus for asthma-related traits.
  14. (2002). Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. doi
  15. (2003). Developmental expression and subcellular localization of wallaby gonadotropin-releasing hormone receptor and its splice variants. doi
  16. (2006). Differential signaling of T cell generation of IL-4 by wild-type and short-deletion variant of type 2 G protein-coupled receptor for vasoactive intestinal peptide (VPAC2). doi
  17. (2001). Dopamine and glutamate induce distinct striatal splice forms of Ania-6, an RNA polymerase II-associated cyclin. doi
  18. (2006). Expression and function of NPSR1/GPRA in the lung before and after induction of asthma-like disease. doi
  19. (2007). Expression of corticotropin-releasing hormone receptor type 1 and type 2 in human pregnant myometrium. doi
  20. (1999). Growth hormonereleasing hormone: an autocrine growth factor for small cell lung carcinoma. doi
  21. Halmos, G.(2001) Inhibition of growth and metastases of MDA-MB-435 human estrogen-independent breast cancers by an antagonist of growth hormone-releasing hormone. doi
  22. (1997). Homer: a protein that selectively binds metabotropic glutamate receptors. doi
  23. (1998). Human corticotropin-releasing hormone receptor: differences in subtype expression between pregnant and non-pregnant myometria. doi
  24. (2006). Human genome polymorphism and alternative splicing.
  25. (2007). Identification of the intracellular region of the leukotriene B4 receptor type 1 that is specifically involved in Gi activation. doi
  26. (1990). Immunomodulation by tachykinin neuropeptides. doi
  27. (2006). Inactivating mutations of LH and FSH receptors--from genotype to phenotype.
  28. (2001). International Human Genome Sequencing Consortium. doi
  29. (2008). Intracellular mechanisms regulating CRH-R2β-endocytosis and interaction with ERK1/2 and p38 MAPK signalling cascades. doi
  30. (2008). Lack of association between genetic variation in Gprotein-coupled receptor for asthma susceptibility and childhood asthma and atopy. doi
  31. (1998). Maternal corticotropin-releasing hormone is increased with impending preterm birth. doi
  32. (2000). Metabotropic glutamate receptors in acutely isolated hippocampal astrocytes: developmental changes of mGluR5 mRNA and functional expression. doi
  33. (2000). Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. doi
  34. (2005). Pharmacological characterization of human and murine neuropeptide S receptor variants.
  35. (2008). Placental corticotrophin-releasing hormone and its receptors in human pregnancy and labour: still a scientific enigma. doi
  36. (2007). Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. doi
  37. (2005). Prognostic and functional significance of thromboxane synthase gene overexpression in invasive bladder cancer.
  38. (2001). Prostaglandins and leukotrienes: advances in eicosanoid biology. doi
  39. (1999). Role of corticotropin-releasing hormone in onset of labour. doi
  40. (1995). Sex steroid hormones change the differential distribution of the isoforms of the D2 dopamine receptor messenger RNA in the rat brain. doi
  41. (2005). Spliceosome-mediated RNA trans-splicing. doi
  42. (2005). Steroid hormone receptor coactivation and alternative RNA splicing by U2AF65-related proteins CAPERα and CAPERβ. doi
  43. (2001). Structural, signalling and regulatory properties of the group I metabotropic glutamate receptors: prototypic family C G-protein-coupled receptors. doi
  44. (2007). The adhesion GPCRs: A unique family of G-protein-coupled receptors with important roles in both central and peripheral tissues. Cell Mol. Life Sci. doi
  45. (2005). The delta-e13 isoform of the calcitonin receptor forms a six-transmembrane domain receptor with dominant-negative effects on receptor surface expression and signaling. doi
  46. (1998). The human placenta and fetal membranes express the corticotropinreleasing hormone receptor 1α (CRH-1α) and the CRH-C variant receptor. doi
  47. (2007). The onset of labour alters corticotropin releasing hormone type 1 receptor (CRHR1) variant expression in human myometrium: putative role of IL-1β. doi
  48. (1994). The PACAP receptor: generation by alternative splicing of functional diversity among G proteincoupled receptors in nerve cells. doi
  49. (1996). Trans-acting factors regulate the expression of CD44 splice variants.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.